Adding Bupropion or Varenicline to NRT After ACS Linked to Lower Mortality
Adding Prescription Meds to Nicotine Patches Lowers Heart Death Risk
This retrospective cohort study of 8,574 propensity-matched pairs found that adding bupropion or varenicline to NRT after ACS was associated…
Heart attack survivors who quit smoking with extra prescription help live longer.
Prospective observational study identifies 2,504 potential drug-drug interactions among hospitalized patients with acute coronary syndrome.
Heart Patients Face Hidden Risks From Common Drug Mixes
This prospective observational cohort study evaluated 371 hospitalized patients with acute coronary syndrome at Assiut University Heart Hosp…
Taking several heart medications at once can create dangerous hidden interactions that increase the risk of treatment failure and hospital s…
Residual global μQFR assessment associated with 3-year MACE risk in acute coronary syndrome patients
Better Heart Maps Predict Long-Term Survival
This post hoc analysis of a randomized controlled trial evaluated 2,428 acute coronary syndrome patients over 36.0 months. High-risk residua…
A new heart map predicts long-term survival just as well as expensive pressure wires, helping doctors spot high-risk patients after stent pr…
Cross-Sectional Study Shows Rising PPI Use in Chinese ACS and AF Patients at Discharge
Why are nearly two-thirds of heart patients now getting stomach acid blockers at discharge?
This cross-sectional study examined 531 Chinese patients with acute coronary syndrome and atrial fibrillation at a Beijing hospital. PPI adm…
Nearly two-thirds of heart patients leaving the hospital now receive stomach acid blockers, a sharp rise from just 21% a decade ago.
Shorter heparin-to-bivalirudin bridging times (≤30 min) reduce hospitalization in acute coronary syndrome patients undergoing PCI.
The Clock Is Ticking When You Switch Blood Thinners During Heart Surgery
This retrospective cohort study evaluated 197 patients with acute coronary syndrome undergoing percutaneous coronary intervention. Analysis …
A simple timing tweak in how two common blood thinners are switched during heart procedures may cut the odds of landing back in the hospital…
AI applications in acute care showed potential but face significant implementation challenges.
AI Is Quietly Changing How ERs Save Lives. Here’s How.
This narrative review examined artificial intelligence (AI) applications in patients within emergency departments and intensive care units. …
Artificial intelligence is moving into emergency rooms to help doctors spot life-threatening problems faster, but it’s not ready to run the …
CI-AKI in ACS patients undergoing PCI was associated with a 4.7-fold increased hazard of death within 90 days.
Dye in Heart Attack Treatment Raises Death Risk
This prospective cohort study evaluated 192 patients with acute coronary syndrome treated with percutaneous coronary intervention. The incid…
A dye used to clear blocked heart arteries can damage kidneys and raise the risk of death within 90 days for patients with acute coronary sy…
Intravascular imaging and FFR-guided PCI reduce major adverse cardiovascular events versus angiography
Advanced imaging and physiology guidance during heart procedures may lower event risk compared to angiography alone
A network meta-analysis of 43 RCTs involving 39,291 patients undergoing PCI found intravascular imaging (IVUS, OCT/OCTA) and fractional flow…
Advanced imaging and physiology guidance during heart procedures may lower event risk compared to angiography alone
Marburg Heart Score and INTERCHEST show modest discrimination comparable to standard protocol for acute chest pain triage.
A Simple Phone Call Could Better Spot a Dangerous Heart Problem
This prospective diagnostic accuracy study evaluated the Marburg Heart Score (MHS) and INTERCHEST score in 280 patients with acute chest pai…
A few extra questions during a late-night call can help nurses better spot dangerous heart attacks while keeping patients with simple chest …
LEGEND rule-out strategy reduces length of stay and testing in suspected ACS patients across four Australian emergency departments
A new strategy safely shortens hospital stays for suspected heart attacks
This stepped-wedge cluster randomized controlled trial evaluated the LEGEND rule-out strategy, which integrates high-sensitivity cardiac tro…
A new hospital strategy safely shortens stays for suspected heart attacks by 3.6 hours while getting more patients home within 4 hours.
Systemic inflammation indices MLR, SIRI, and AISI associated with carotid plaques in ACS patients
Could simple blood tests help spot hidden stroke risk after a heart attack?
A retrospective cohort study of 7178 ACS patients found that higher MLR, SIRI, and AISI indices were associated with increased odds of carot…
Simple blood tests can flag hidden stroke risk after a heart attack by spotting dangerous plaque buildup in the neck.
Phase 3 trial of milvexian for ACS prevention completes enrollment
Can a new drug help prevent heart attacks and strokes after a serious heart event?
The LIBERATE trial, a Phase 3 study, has completed enrollment of 14,194 participants with a recent acute coronary syndrome to evaluate if mi…
A new drug called milvexian is being tested to see if it lowers the risk of death, heart attack, or stroke after a serious heart event.